STOCK TITAN

Lantheus to Present at the J.P. Morgan 2023 Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Lantheus Holdings (NASDAQ: LNTH) announced that Mary Anne Heino, President and CEO, will present at the J.P. Morgan 2023 Healthcare Conference on January 11, 2023, at 1:30 p.m. PST. The webcast of the presentation will be accessible via the Investors section of the company’s website, where it will also be replayable for at least 30 days. Lantheus is focused on diagnostics, radiotherapeutics, and AI solutions to enhance patient outcomes and has over 65 years of experience in the healthcare sector.

Positive
  • None.
Negative
  • None.

NORTH BILLERICA, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, today announced Mary Anne Heino, President and Chief Executive Officer, will present at the J.P. Morgan 2023 Healthcare Conference at 1:30 p.m. PST on Wednesday, January 11.

To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation.

About Lantheus
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com.

Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com

Melissa Downs
Senior Director, Corporate Communications
646-975-2533
media@lantheus.com


FAQ

When will Lantheus Holdings present at the J.P. Morgan 2023 Healthcare Conference?

Lantheus Holdings will present on January 11, 2023, at 1:30 p.m. PST.

How can I access the Lantheus Holdings presentation at the healthcare conference?

You can access the presentation via the Investors section on Lantheus Holdings' website.

What is the focus of Lantheus Holdings' business?

Lantheus Holdings focuses on improving patient outcomes through diagnostics, radiotherapeutics, and AI solutions.

Is there a replay available for the Lantheus Holdings presentation?

Yes, a replay will be available on the company’s website for at least 30 days after the presentation.

Lantheus Holdings, Inc

NASDAQ:LNTH

LNTH Rankings

LNTH Latest News

LNTH Stock Data

6.28B
67.75M
2.47%
106.95%
6.41%
Drug Manufacturers - Specialty & Generic
In Vitro & in Vivo Diagnostic Substances
Link
United States of America
NORTH BILLERICA